lung cancer

2017 ASCO Annual Meeting. #ASCO17
June 5, 2017 · Greg Guthrie, ASCO staff
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Today’s key research highlights include CAR T-cell therapy for multiple myeloma, immune checkpoint inhibitors for mesothelioma, and targeted therapy advances for non-small cell lung cancer and HER2-positive breast cancer. Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 4, 2017 · Greg Guthrie, ASCO staff
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research released today covers how using a web-based system to report symptoms helps patients live longer, a shorter schedule of chemotherapy can be an option for certain people with colon cancer, and a targeted therapy may slow the growth of BRCA-related breast cancer. Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 3, 2017 · Greg Guthrie, ASCO staff
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing. Read More >>
2017 ASCO Annual Meeting. #ASCO17
May 17, 2017 · Monika Joshi, ASCO Staff
Read highlighted cancer research that will be presented at the 2017 ASCO Annual Meeting, where oncology professionals from around the globe will gather in Chicago in June. Read More >>
April 6, 2017 · Nathan A. Pennell, MD, PhD
The Multidisciplinary Thoracic Cancers Symposium brings oncology professionals together to discuss ways to best treat people with lung cancer and other thoracic cancers. Dr. Nathan Pennell describes some of the research presented on targeted therapy, radiation therapy, and health disparities. Read More >>

Pages